Marimed (MRMD) Free Cash Flow (QoQ) (2013 - 2026)
Marimed (MRMD) Free Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 163.72% |
| Mar 31, 2026 | -52.48% |
| Dec 31, 2025 | 42.22% |
| Sep 30, 2025 | 205.60% |
| Jun 30, 2025 | -226.87% |
| Mar 31, 2025 | 169.82% |
| Dec 31, 2024 | -195.98% |
| Sep 30, 2024 | -125.04% |
| Jun 30, 2024 | 1,356.33% |
| Mar 31, 2024 | 92.64% |
| Dec 31, 2023 | -136.39% |
| Sep 30, 2023 | 4,820.00% |
| Jun 30, 2023 | 97.21% |
| Mar 31, 2023 | -357.92% |
| Dec 31, 2022 | -22.63% |
| Sep 30, 2022 | 129.30% |
| Jun 30, 2022 | -271.20% |
| Mar 31, 2022 | 143.66% |
| Dec 31, 2021 | -211.95% |
| Sep 30, 2021 | -4.95% |